Early oncology portfolio execution roadmap

The challenge

We worked with our client to develop a forward-looking early development program evaluation tool that identifies key inflection points, value drivers and risks for the client’s early oncology portfolio. (US was the geographic scope).

Our solution

• Developed a dynamic excel-based tool for program evaluation with key dimensions, value, risk, and inflection points over time
• Filled in gaps using external benchmarks including key program metrics such as timing, cost and risk
• Developed standalone commercial forecast and valuation for each program (n=17) accounting for opportunity size, competitive dynamics, pricing, cost and PTRS considerations
• Developed current and future portfolio snapshot and outcomes
• Ensured repeatable process for future updates over time

The results

We delivered a commercial analysis of the portfolio with regards to relative potential of the programs along with their key value drivers, milestones, risks and gaps over a 10-year time horizon for key stakeholders.